o.cousineau

TL3 Regular · Zlín, CZ

Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.

Joined 5 August 2024 · last posted 23h

136 posts, newest first. Showing up to 150.

Journal club: what we got wrong in an earlier session Replied, post #126 · Evidence › Journal club · 27 Jul 2026 · 8 likes Building on post #125 rather than restating it. The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first…
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #49 · Analytics › Mass spectrometry · 25 Jul 2026 · 12 likes Where I part company with post #45, and it is a narrow parting. Resolution: "high resolution" commonly means
Private prescribing in the UK: what is actually involved Replied, post #73 · Regional › UK & Ireland · 23 Jul 2026 · 26 likes On private prescribing, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
Micro-titration: a disputed topic, argued properly Replied, post #107 · Practice › Dosing & titration · 19 Jul 2026 · 0 likes My experience of micro-titration contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #59 · Practice › Side effects · 18 Jul 2026 · 0 likes Answering the question post #57 raises rather than the one it answers. Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason…
Tracking a shortage from primary sources rather than rumour Replied, post #106 · Access › Shortages · 16 Jul 2026 · 1 like I read post #104 twice before replying, because I had assumed the opposite. A note on scope: what I am saying about tracking a shortage applies to the case in the first…
Revisiting: The best-written scientific paper you have read Replied, post #94 · Lounge › Off topic · 16 Jul 2026 · 0 likes I would call the community position on best-written scientific paper likely rather than established, and I would be comfortable defending that hedge.
Pooling trials with different estimands Replied, post #90 · Evidence › Meta-analyses · 12 Jul 2026 · 3 likes Pooling trials with different estimands is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Revisiting: The best-written scientific paper you have read Replied, post #83 · Lounge › Off topic · 10 Jul 2026 · 3 likes Trying to state the best-written scientific paper position in a way that someone who disagrees would recognise as fair, because I do not think the version in this…
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #22 · Clinical › Comorbidities · 10 Jul 2026 · 0 likes I had written a reply contradicting post #18 and deleted it. Here is what survived. A request rather than an answer: could whoever has the primary source for…
Asking a follow-up: new topic or new reply? Replied, post #46 · Start Here › How to Ask · 10 Jul 2026 · 0 likes Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can change them later.
Programming during a large energy deficit Replied, post #35 · Nutrition & Training › Resistance training · 8 Jul 2026 · 30 likes Picking up post #34: that is the part I would want checked first. Machine-based work is often better tolerated when energy is low and is not inferior for this purpose.…
What to bring: records that a clinician can actually use — a second dataset Replied, post #6 · Clinical › Prescriber conversations · 4 Jul 2026 · 13 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That distinction has done more work for me than…
Revisiting: The best-written scientific paper you have read Replied, post #68 · Lounge › Off topic · 3 Jul 2026 · 10 likes If someone has run best-written scientific paper properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #47 · Access › International · 30 Jun 2026 · 11 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. It is one reading of the data and not…
Follow-up: Reading an interaction checker output critically Replied, post #23 · Practice › Interactions · 29 Jun 2026 · 6 likes I had written a reply contradicting post #19 and deleted it. Here is what survived. SGLT2 inhibitors: frequently co-administered and relevant to renal and…
Coming back to: A structured critique template this community uses Replied, post #40 · Evidence › Study critique · 23 Jun 2026 · 24 likes Post #39 answers the question as asked. The question underneath it is different. I would be cautious about generalising from the structured critique template example…
Designing a personal experiment that could change your mind — one year on Replied, post #63 · Research Methods › N-of-1 designs · 20 Jun 2026 · 11 likes Everything in post #61 holds. The case it does not cover is the one I have. An n of one tells you about one person, which is the person you are most interested in. That…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #24 · Access › Insurance & coverage · 17 Jun 2026 · 5 likes I came in to disagree and I am leaving without a disagreement.
Racemisation and why it is invisible to a mass measurement Replied, post #95 · Analytics › Impurities & related substances · 14 Jun 2026 · 5 likes My experience of racemisation contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
Micronutrient adequacy at low total intake Replied, post #53 · Nutrition & Training › Protein & intake · 10 Jun 2026 · 10 likes Picking up post #51: that is the part I would want checked first. Nothing here is medical or dietetic advice, and a dietitian is the professional this subcategory most…
Journal club: LEADER as the historical anchor Replied, post #86 · Evidence › Journal club · 8 Jun 2026 · 26 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. The part I…
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #22 · Evidence › Journal club · 7 Jun 2026 · 3 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. The disagreement above is smaller than it looks once…
Talking to a therapist about this specifically Replied, post #10 · Wellbeing › Mental health · 5 Jun 2026 · 0 likes Coming back to post #6, because the follow-up matters more than the original answer. The social side of this — how other people respond to visible change — comes up…
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #69 · Practice › Administration · 4 Jun 2026 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Coming back to: A structured critique template this community uses Replied, post #25 · Evidence › Study critique · 3 Jun 2026 · 27 likes Where a critique changes your position, saying so in the thread is worth more than being right, and it is the thing this subcategory does better than most places.
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #7 · Clinical › Bloodwork · 30 May 2026 · 0 likes Post #4 is the version of this I will quote in future. One addition. Counterpoint on HbA1c lag, offered without confidence: the same observation is consistent with a…
Prescription portability between countries Replied, post #44 · Access › International · 26 May 2026 · 0 likes Adding a reference point for prescription portability between countries. Mine is a single case, collected without controls, and I am posting the method alongside it so…
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #20 · Compounds › Oral incretins · 26 May 2026 · 2 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #40 · Practice › Storage & stability · 24 May 2026 · 8 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I would be interested in a…
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #108 · Devices › Syringes & needles · 11 May 2026 · 13 likes Two claims get bundled together under 0.3 ml versus 0.5 ml and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
Second pass at: When your prescriber and the evidence disagree Replied, post #20 · Clinical › Prescriber conversations · 10 May 2026 · 20 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
Revisiting: Body image changing more slowly than the body Replied, post #4 · Wellbeing › Mental health · 4 May 2026 · 3 likes Post #2 and I disagree about the size of the effect, not about the direction. Identity and self-image: for some people, weight and body size are central to identity.…
CJC-1295 with and without DAC: what the modification does Replied, post #47 · Compounds › Secretagogues & GH axis · 2 May 2026 · 8 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
Does a peptide degrade silently, with no visual change? Replied, post #19 · Practice › Storage & stability · 1 May 2026 · 12 likes Thank you for taking the time. That was more work than a reply usually is.
Journal club: is percentage weight change the right endpoint? Replied, post #98 · Evidence › Journal club · 24 Apr 2026 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #60 · Practice › Reconstitution · 21 Apr 2026 · 3 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #96 · Sourcing › Vendor reports · 18 Apr 2026 · 8 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable.
Citation sweep results: how many references did not say what was claimed Replied, post #75 · Meta › Wiki maintenance · 10 Apr 2026 · 0 likes Post #73 put the caveat in the right place and I want to underline it. Question for the editors: what is the standard for adding a citation to a claim that is community…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #20 · Clinical › Bloodwork · 10 Apr 2026 · 0 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Liver enzymes drifting would be much easier to settle if anyone reported the…
Choosing which test to pay for, given a fixed budget Replied, post #60 · Sourcing › Independent verification · 8 Apr 2026 · 0 likes Taking post #59 at face value and following it one step further. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #34 · Evidence › Trials · 6 Apr 2026 · 20 likes Posting my Subgroup analyses numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
Reconstitution volumes that produce round numbers, tabulated Replied, post #79 · Practice › Reconstitution · 31 Mar 2026 · 13 likes Post #78 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #16 · Compounds › Oral incretins · 27 Mar 2026 · 17 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
Personal import allowances, compared — a second dataset Replied, post #88 · Access › International · 19 Mar 2026 · 4 likes The question underneath Personal import allowances is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what…
Bioimpedance and hydration: why the number moves Replied, post #17 · Outcomes › Body composition · 13 Mar 2026 · 14 likes What I would want before treating bioimpedance and hydration as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three…
Revisiting: Maintainer handover: how it works Replied, post #34 · Meta › Wiki maintenance · 6 Mar 2026 · 13 likes Good question, well framed, and I would like to see it answered properly.
Grapefruit: why this class is not the class that cares Replied, post #2 · Practice › Interactions · 28 Feb 2026 · 11 likes Adding the measurement that the opening post says would settle it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body…
Managing an unplanned gap in supply Replied, post #45 · Access › Shortages · 28 Feb 2026 · 18 likes I had written a reply contradicting post #41 and deleted it. Here is what survived. Resuming after a gap: after a gap of days or a few weeks, most people resume at the…
Measurement error in a self-reported exposure Replied, post #14 · Evidence › Study critique · 22 Feb 2026 · 7 likes Picking up post #13: that is the part I would want checked first. What I want from this measurement error thread is the list of things that would need to be true for…
A widely repeated interaction claim that turns out to be unsupported Replied, post #29 · Practice › Interactions · 19 Feb 2026 · 25 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #19 · Compounds › Tirzepatide · 18 Feb 2026 · 5 likes SURMOUNT-4's randomised withdrawal design is the strongest available evidence about what happens on stopping. It says nothing about a lower maintenance dose, because…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #28 · Outcomes › Body composition · 16 Feb 2026 · 4 likes I had written a reply contradicting post #26 and deleted it. Here is what survived. Resting metabolic rate: body composition affects metabolic rate. As fat mass…
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #57 · Start Here › How to Ask · 28 Jan 2026 · 0 likes Confirming post #56 from a second method, which matters more than confirming it from a second person. If the answer you got does not fit your case, say which part does…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #57 · Documentation › Wiki requests · 27 Jan 2026 · 9 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. If the premise is wrong, everything after…
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #11 · Analytics › Mass spectrometry · 17 Jan 2026 · 0 likes The claim about Adducts upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
A partial dose because the pen emptied mid-injection Replied, post #107 · Practice › Administration · 10 Jan 2026 · 31 likes The version of partial dose because the pen that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
Reading an interaction checker output critically Replied, post #86 · Practice › Interactions · 7 Jan 2026 · 26 likes I had written a reply contradicting post #84 and deleted it. Here is what survived. Alcohol is not contraindicated in the labelling and it does irritate a stomach that…
When to stop reading forums, including this one Replied, post #68 · Wellbeing › Mental health · 28 Dec 2025 · 18 likes Comparing your own experience to a trial average is a poor use of a trial average, particularly for outcomes as variable as this one.
Availability by country, dated, with primary sources — one year on Replied, post #9 · Access › International · 22 Dec 2025 · 25 likes Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly. Adding the…
The decimal-point error, and the habit that catches it Replied, post #82 · Practice › Reconstitution · 17 Dec 2025 · 0 likes Post #80 is the version of this I will quote in future. One addition. The version of decimal-point error that I was taught turned out to be a teaching simplification.…
Tracking a preprint to publication: a worked example Replied, post #138 · Evidence › Preprints · 13 Dec 2025 · 13 likes Where numbers change between preprint and published version, the changes are not random. They tend toward a smaller effect and a more carefully hedged claim.
Prescription requirements and telehealth models Replied, post #65 · Sourcing › Regulatory · 13 Dec 2025 · 0 likes Worth separating two things that post #61 runs together. Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are…
Prescription requirements and telehealth models Replied, post #58 · Sourcing › Regulatory · 10 Dec 2025 · 0 likes No notes. Posting so the count is not one.
Substitution between formats during a shortage Replied, post #90 · Access › Shortages · 6 Nov 2025 · 6 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #50 · Evidence › Journal club · 31 Oct 2025 · 31 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
A parcel that arrived warm: a decision process, not a verdict Replied, post #113 · Practice › Storage & stability · 31 Oct 2025 · 29 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. I would call that…
New subcategory: rationale and scope Replied, post #126 · Meta › Announcements · 26 Oct 2025 · 9 likes Offering a way to settle new subcategory rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #72 · Start Here › How to Ask · 20 Oct 2025 · 10 likes Do not apologise in the first line. It costs you the space where the question should be, and nobody here thinks a question is an imposition. If that reads as pedantic,…
Follow-up: Constipation management, with a dietitian's contribution Replied, post #6 · Practice › Side effects · 18 Oct 2025 · 15 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Tracking that stops updating and then resumes Replied, post #34 · Sourcing › Logistics · 9 Oct 2025 · 4 likes A tracking gap at a customs facility is the most common cause of an unexpectedly long transit and the segment nobody has visibility of.
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #50 · Analytics › COA interpretation · 29 Sep 2025 · 1 like Everything in post #47 holds. The case it does not cover is the one I have. Asking for the batch record rather than the certificate is a reasonable request and the…
Comparing my trajectory with the trial curves, carefully Replied, post #54 · Outcomes › Progress reports · 27 Sep 2025 · 3 likes Confirming post #53 from a second method, which matters more than confirming it from a second person. The best progress reports here read as records rather than as…
Power cut for eleven hours: how I assessed it afterwards Replied, post #68 · Practice › Storage & stability · 23 Sep 2025 · 1 like I would put moderate confidence on the mainstream reading of power cut for eleven hours and no more. That is not scepticism for its own sake; it is where the sourcing…
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #54 · Practice › Storage & stability · 16 Sep 2025 · 0 likes Everything in post #50 holds. The case it does not cover is the one I have. Careful with the language on Freeze-thaw. "Not detected" and "not present" are different…
Follow-up: Why appetite effects are mostly central Replied, post #40 · Pharmacology › Receptor biology · 13 Sep 2025 · 0 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want. That…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #72 · Devices › Cold chain · 4 Sep 2025 · 4 likes Noted, and I have changed what I was going to do on the strength of it.
IGF-1 as a surrogate endpoint and its limitations Started this topic · Compounds › Secretagogues & GH axis · 2 Sep 2025 · 57 likes IGF-1 as a surrogate endpoint and its limitations Writing it up because I had to work it out twice and would rather nobody else did. IGF-1, and specifically the version…
Asking about a compound your prescriber has not heard of Replied, post #138 · Clinical › Prescriber conversations · 26 Aug 2025 · 0 likes Taking post #135 at face value and following it one step further. Asking about the plan if the first approach does not work is a good use of an appointment and is…
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #28 · Start Here › Welcome · 19 Aug 2025 · 7 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
Angle of injection and whether 90 degrees is always right Replied, post #8 · Practice › Administration · 7 Aug 2025 · 0 likes That is consistent with mine, for whatever one more account is worth.
How to research a compound with no human data without deceiving yourself Replied, post #33 · Compounds › Other compounds · 31 Jul 2025 · 9 likes Worth separating two things that post #29 runs together. Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is…
Why the timeline is on the right and not the left Replied, post #47 · Meta › Site feedback · 29 Jul 2025 · 11 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Follow-up: Why we hide unevidenced fraud accusations and log the hiding Replied, post #9 · Sourcing › Red flags · 25 Jul 2025 · 15 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. Adding the caveat now…
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #41 · Analytics › Method validation · 17 Jul 2025 · 4 likes Post #37 put the caveat in the right place and I want to underline it. Something worth flagging about Forced degradation studies: the strongest-sounding claims in this…
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #14 · Compounds › Secretagogues & GH axis · 16 Jul 2025 · 25 likes Taking post #11 at face value and following it one step further. Published human data on most of this family is thin, old, or from small studies with surrogate…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #13 · Compounds › Retatrutide · 16 Jul 2025 · 0 likes Worth separating two things that post #9 runs together. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the…
Anxiety in the first weeks: drug, situation, or both Replied, post #114 · Wellbeing › Mental health · 9 Jul 2025 · 11 likes Support here is genuine and is not a substitute for care, and saying both is not a contradiction. Old habit: I write down the expected answer before I calculate it.
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #7 · Compounds › Semaglutide · 26 Jun 2025 · 26 likes If you are new and reading this thread for the answer to semaglutide solutions: the answer is conditional, the conditions are in the third reply, and the rest of the…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #25 · Access › Insurance & coverage · 25 Jun 2025 · 0 likes Two things can be true about Reading a denial letter at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
Anxiety in the first weeks: drug, situation, or both Replied, post #103 · Wellbeing › Mental health · 16 Jun 2025 · 0 likes Counterpoint on anxiety, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
[2026 update] An appeal that failed, and what I would do differently Replied, post #124 · Access › Insurance & coverage · 15 Jun 2025 · 11 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Half-life, steady state, and accumulation worked through Replied, post #85 · Pharmacology › Pharmacokinetics · 8 Jun 2025 · 1 like Worth separating two things that post #83 runs together. Half-life: I have looked for the primary source twice and failed twice. Either it does not exist or it is…
Why plausible mechanism is not evidence of effect Replied, post #13 · Compounds › Repair & healing peptides · 1 Jun 2025 · 0 likes On post #11 — agreed on the reasoning, with one qualification. Plausible mechanism came up in a thread eighteen months ago and was answered well. I cannot find it,…
Pre-registering a personal experiment, seriously Replied, post #33 · Research Methods › N-of-1 designs · 28 May 2025 · 0 likes Write down what you would accept as evidence that it did not work, before starting. That one sentence turns an anecdote into an experiment. I would treat that as a…
Price changes over 2025 and 2026, tabulated and dated Replied, post #2 · Access › Pricing · 27 May 2025 · 9 likes Agreed, and I will stop repeating the version of this I had been repeating.
Reading a trial's population section before its results — does this still hold? Replied, post #142 · Evidence › Trials · 24 May 2025 · 4 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
When to stop reading forums, including this one — the long version Replied, post #20 · Wellbeing › Mental health · 16 May 2025 · 0 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well.
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #33 · Clinical › Comorbidities · 14 May 2025 · 4 likes Something worth flagging about Cardiovascular risk: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and…
Coming back to: Why the cheapest option is often not the cheapest Replied, post #20 · Access › Pricing · 14 May 2025 · 26 likes Adding the measurement that post #17 says would settle it. What I want from this cheapest option thread is the list of things that would need to be true for the claim…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #2 · Data & Tools › Calculators · 10 May 2025 · 6 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Adding a reference point for titration planner refuses. Mine is a single…
Triple agonism: additive, synergistic, or neither? Replied, post #44 · Compounds › Retatrutide · 9 May 2025 · 11 likes Source for the triple agonism figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than…
Washout: how long is long enough, and for what purpose Replied, post #24 · Pharmacology › Pharmacokinetics · 7 May 2025 · 17 likes The confident answers on washout and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
About the Secretagogues & GH axis category Replied, post #7 · Compounds › Secretagogues & GH axis · 25 Apr 2025 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Requesting a page: what makes a good request Replied, post #65 · Documentation › Wiki requests · 21 Apr 2025 · 3 likes A document with no maintainer becomes wrong quietly, which is worse than not existing, because it carries the authority of a maintained page.
Sequence verification for an obscure compound: how it is done Replied, post #12 · Compounds › Other compounds · 14 Apr 2025 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Carryover and the ghost peak from last week's standard Replied, post #50 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 0 likes Answering the question post #48 raises rather than the one it answers. On carryover: the maintained page in the documentation commons covers the general case with…
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #50 · Devices › Syringes & needles · 4 Apr 2025 · 4 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
A certificate with no method stated: what can you conclude? Replied, post #11 · Analytics › COA interpretation · 31 Mar 2025 · 1 like Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Coverage for the indication versus for the drug — a second dataset Replied, post #47 · Access › Insurance & coverage · 27 Mar 2025 · 1 like Confirming post #46 from a second method, which matters more than confirming it from a second person. Formulary status: the list of covered medications and the tier…
Charge states for a 4 kDa peptide, worked through Replied, post #60 · Analytics › Mass spectrometry · 9 Mar 2025 · 0 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
Counter-ion form: the field almost nobody reports — one year on Replied, post #33 · Analytics › COA interpretation · 27 Feb 2025 · 19 likes The signature block matters more than it appears to. A named individual with a date is a different kind of document from an unsigned one, whatever the numbers say.
Telehealth prescribing models in the US Replied, post #61 · Regional › North America · 21 Feb 2025 · 0 likes Post #57 put the caveat in the right place and I want to underline it. Compounded preparations and authorised products are different regulatory categories with…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #44 · Access › International · 14 Feb 2025 · 0 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site.
Review: a draft on reconstitution arithmetic, with objections Replied, post #21 · Documentation › Doc review · 13 Feb 2025 · 7 likes Review the scope as well as the content. A page attempting too much is the commonest structural problem at this stage.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #147 · Practice › Dosing & titration · 12 Jan 2025 · 10 likes Something worth flagging about four-week escalation interval: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual…
Fixed versus detachable needles: the trade-offs Replied, post #101 · Devices › Syringes & needles · 9 Jan 2025 · 29 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #33 · Compounds › Secretagogues & GH axis · 2 Jan 2025 · 24 likes Two sentences on pulsatile secretion and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #53 · Sourcing › Regulatory · 29 Dec 2024 · 0 likes Posting my Research-use-only labelling numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #128 · Compounds › Oral incretins · 29 Dec 2024 · 9 likes Good question, well framed, and I would like to see it answered properly.
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Replied, post #3 · Clinical › Comorbidities · 28 Dec 2024 · 18 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable. This has been…
Converting between mg/mL and units per dose, both directions Replied, post #123 · Practice › Reconstitution · 9 Dec 2024 · 22 likes Where I part company with post #119, and it is a narrow parting. Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It…
Promotion criteria, and the one that stops most nominations Replied, post #134 · Documentation › Doc review · 7 Dec 2024 · 1 like Post #133 answers the question as asked. The question underneath it is different. The four criteria are that the question recurs, that the content is correct and…
[2026 update] New subcategory: rationale and scope Replied, post #38 · Meta › Announcements · 2 Dec 2024 · 9 likes Post #36 and I disagree about the size of the effect, not about the direction. Notifications: watching this subcategory means you receive notifications when…
Why "any advice?" is the least effective ending for a post Replied, post #85 · Start Here › How to Ask · 29 Nov 2024 · 0 likes Tag your own topic. Two accurate tags do more for how findable it is than a long title, and you can change them later. I would want to see it done twice before…
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #28 · Clinical › Special populations · 26 Nov 2024 · 0 likes Post #26 and I disagree about the size of the effect, not about the direction. Extrapolating a point estimate to somebody well outside the enrolled range should be…
Two sessions a week versus four: what the evidence supports Replied, post #12 · Nutrition & Training › Resistance training · 23 Nov 2024 · 23 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum.
Revisiting: Moderation log format change Replied, post #20 · Meta › Announcements · 8 Nov 2024 · 3 likes Post #16 describes the usual case. This is about the unusual one. Supportive, with one reservation worth stating in public: the change makes a common case slightly…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #92 · Analytics › COA interpretation · 22 Oct 2024 · 0 likes Field-by-field walk through a certificate: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to…
Air bubbles in a subcutaneous injection: the honest risk assessment Replied, post #6 · Practice › Administration · 19 Oct 2024 · 0 likes Post #4 is the version of this I will quote in future. One addition. Air in the syringe is a much smaller problem subcutaneously than the anxiety about it suggests, and…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #7 · Sourcing › Red flags · 18 Oct 2024 · 14 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #53 · Analytics › Method validation · 17 Oct 2024 · 26 likes Reading rather than answering, but this is the post I would point somebody at.
US compounding rules and how they changed Replied, post #16 · Regional › North America · 8 Oct 2024 · 0 likes Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end.
A rising related-substance total over six months: degradation or method drift? Replied, post #25 · Analytics › Impurities & related substances · 1 Sep 2024 · 0 likes I read the earlier replies on rising related-substance twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
How to ask for a dose change without antagonising anyone Replied, post #16 · Clinical › Prescriber conversations · 19 Aug 2024 · 1 like I read post #14 twice before replying, because I had assumed the opposite. A question phrased as "what would you want to see before considering X" is answerable and is…
Promotion criteria, and the one that stops most nominations Replied, post #40 · Documentation › Doc review · 17 Aug 2024 · 15 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.